Curis, Inc. (CRIS): Price and Financial Metrics

Curis, Inc. (CRIS): $0.77

-0.04 (-4.68%)

POWR Rating

Component Grades













Add CRIS to Watchlist
Sign Up

Industry: Biotech



in industry


  • CRIS scores best on the Sentiment dimension, with a Sentiment rank ahead of 79.69% of US stocks.
  • CRIS's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • CRIS ranks lowest in Momentum; there it ranks in the 4th percentile.

CRIS Stock Summary

  • Of note is the ratio of CURIS INC's sales and general administrative expense to its total operating expenses; just 14.7% of US stocks have a lower such ratio.
  • For CRIS, its debt to operating expenses ratio is greater than that reported by only 12.08% of US equities we're observing.
  • The volatility of CURIS INC's share price is greater than that of 94.98% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to CURIS INC, a group of peers worth examining would be SLDB, MCRB, ADAP, SGTX, and TGTX.
  • CRIS's SEC filings can be seen here. And to visit CURIS INC's official web site, go to

CRIS Valuation Summary

  • In comparison to the median Healthcare stock, CRIS's price/earnings ratio is 106.03% lower, now standing at -1.4.
  • CRIS's EV/EBIT ratio has moved down 0.6 over the prior 243 months.

Below are key valuation metrics over time for CRIS.

Stock Date P/S P/B P/E EV/EBIT
CRIS 2022-11-25 7.8 1.4 -1.4 -0.9
CRIS 2022-11-23 7.8 1.4 -1.4 -0.9
CRIS 2022-11-22 7.6 1.4 -1.3 -0.9
CRIS 2022-11-21 7.8 1.5 -1.4 -0.9
CRIS 2022-11-18 8.0 1.5 -1.4 -1.0
CRIS 2022-11-17 8.0 1.5 -1.4 -1.0

CRIS Growth Metrics

    Its 5 year revenue growth rate is now at 45.42%.
  • The 4 year cash and equivalents growth rate now stands at -48.15%.
  • The 3 year price growth rate now stands at -52.36%.
CRIS's revenue has moved up $2,883,000 over the prior 70 months.

The table below shows CRIS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 10.41 -50.24 -58.963
2022-06-30 10.624 -46.728 -56.72
2022-03-31 10.517 -41.255 -51.618
2021-12-31 10.649 -37.619 -45.436
2021-09-30 10.538 -35.163 -39.333
2021-06-30 10.241 -31.43 -34.256

CRIS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CRIS has a Quality Grade of C, ranking ahead of 36.2% of graded US stocks.
  • CRIS's asset turnover comes in at 0.066 -- ranking 302nd of 682 Pharmaceutical Products stocks.
  • YMTX, VTRS, and KDNY are the stocks whose asset turnover ratios are most correlated with CRIS.

The table below shows CRIS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.066 0.950 -0.571
2021-03-31 0.085 0.950 -0.771
2020-12-31 0.135 0.951 -1.416
2020-09-30 0.291 0.951 -5.061
2020-06-30 0.301 0.951 -6.257
2020-03-31 0.287 0.952 -7.307

CRIS Price Target

For more insight on analysts targets of CRIS, see our CRIS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $23.00 Average Broker Recommendation 1.5 (Moderate Buy)

CRIS Stock Price Chart Interactive Chart >

Price chart for CRIS

CRIS Price/Volume Stats

Current price $0.77 52-week high $5.27
Prev. close $0.81 52-week low $0.68
Day low $0.77 Volume 534,000
Day high $0.82 Avg. volume 2,412,003
50-day MA $0.79 Dividend yield N/A
200-day MA $1.29 Market Cap 74.44M

Curis, Inc. (CRIS) Company Bio

Curis, Inc. engages in the discovery and development of drug candidates for the treatment of human cancers. The company was founded in 2000 and is based in Lexington, Massachusetts.

CRIS Latest News Stream

Event/Time News Detail
Loading, please wait...

CRIS Latest Social Stream

Loading social stream, please wait...

View Full CRIS Social Stream

Latest CRIS News From Around the Web

Below are the latest news stories about CURIS INC that investors may wish to consider to help them evaluate CRIS as an investment opportunity.

Curis Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag

Curis ( NASDAQ:CRIS ) Third Quarter 2022 Results Key Financial Results Revenue: US$2.83m (down 7.0% from 3Q 2021). Net...

Yahoo | November 12, 2022

This biotech just laid off 30% of its staff. The CEO called the move 'counterintuitive'

A Lexington biotech is laying off nearly one-third of its workforce, and it's not for the usual reasons.

Yahoo | November 10, 2022

Curis (CRIS) Receives a Buy from JonesTrading

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Curis (CRIS - Research Report), with a price target of $5.00. The company's shares closed today at $0.72.Roy covers the Healthcare sector, focusing on stocks such as Curis, Aeglea Biotherapeutics, and Day One Biopharmaceuticals. According to TipRanks, Roy has an average return of 8.3% and a 34.17% success rate on recommended stocks. Curis has an analyst consensus of Moderate Buy, with a price target consensus of $11.50.See today’s best-performing stocks on TipRanks >>Based on Curis' latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $2.

Brian Anderson on TipRanks | November 9, 2022

Curis Provides Third Quarter 2022 Business Update

Data from additional patients in the TakeAim Leukemia trial of emavusertib to be presented during ASH 2022 Curis focuses its resources to drive the development of emavusertib Cash runway extended into 2025 Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass., Nov. 9,…

PR Newswire | November 9, 2022

Investing in Curis Inc. (CRIS) might be a great opportunity, but the stock is a bit overvalued

In Tuesday’s session, Curis Inc. (NASDAQ:CRIS) marked $0.78 per share, up from $0.78 in the previous session. While Curis Inc. has overperformed by 0.04%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CRIS fell by -87.02%, with highs and lows ranging from $6.37 to $0.68, whereas […]

US Post News | November 9, 2022

Read More 'CRIS' Stories Here

CRIS Price Returns

1-mo -3.77%
3-mo -15.75%
6-mo -18.09%
1-year -84.22%
3-year -57.22%
5-year -82.40%
YTD -83.82%
2021 -41.88%
2020 381.76%
2019 146.38%
2018 -80.29%
2017 -77.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7399 seconds.